ArticleJournal of cell science2026
A RhoGEF activates RacM to selectively promote motility without affecting macropinocytosis in Entamoeba histolytica.
Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Rho guanine nucleotide-exchange factors (RhoGEFs) activate Rho and Rac small GTPases, orchestrating cellular processes, such as actin remodeling, endocytosis and migration. In the protozoan parasite Entamoeba histolytica, the causative agent of amebiasis, 22 Rho GTPases and ∼62 Dbl-homology (DH) domain-containing RhoGEFs have been identified, yet most remain uncharacterized. Our previous work revealed that E. histolytica (Eh)RacM (also known as EhRho13) negatively regulates macropinocytosis while promoting directional migration. Here, we characterize a previously uncharacterized RhoGEF, EHI_158230 (designated EhGEFM), identified as a potential EhRacM interactor through interactome analysis. Co-immunoprecipitation and in vitro GEF assays confirmed that EhGEFM directly binds and specifically activates EhRacM. Although EhgefM silencing did not affect macropinocytosis, it impaired directional migration, partially phenocopying EhracM silencing. Fixed and live-cell imaging revealed colocalization of EhGEFM and EhRacM at the cell periphery; notably, only EhRacM was recruited to maturing macropinosomes following actin coat disassembly. These findings indicate that although EhRacM is involved in both macropinocytosis and directional migration, its activator EhGEFM is required only for directional migration. This study provides the first direct evidence of distinct regulatory pathways governing Rho small GTPase function in E. histolytica.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.